158 related articles for article (PubMed ID: 7678920)
1. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
Hryniuk W
N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
[No Abstract] [Full Text] [Related]
2. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
3. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
4. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
[TBL] [Abstract][Full Text] [Related]
5. CHOP therapy: has shorter-course therapy had an impact on lymphomas?
Gaynor ER; Fisher RI
Cancer Invest; 1998; 16(1):26-32. PubMed ID: 9474248
[No Abstract] [Full Text] [Related]
6. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
8. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
[TBL] [Abstract][Full Text] [Related]
9. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
[No Abstract] [Full Text] [Related]
10. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
Santhosh-Kumar CR; Ajarim DS; Shipkey FD
Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
12. The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
Adams HJA; Kwee TC
Ann Hematol; 2018 Apr; 97(4):719-720. PubMed ID: 29222579
[No Abstract] [Full Text] [Related]
13. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Alliot C
J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
[No Abstract] [Full Text] [Related]
14. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
15. Cervical spontaneous epidural hematoma as a complication of non-Hodgkin's lymphoma.
Mastronardi L; Carletti S; Frondizi D; Spera C; Maira G
Eur Spine J; 1996; 5(4):268-71. PubMed ID: 8886740
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome.
Cáceres W
Bol Asoc Med P R; 1995; 87(10-12):158-61. PubMed ID: 8924158
[TBL] [Abstract][Full Text] [Related]
17. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
Ann Oncol; 1994; 5 Suppl 2():91-5. PubMed ID: 7515652
[TBL] [Abstract][Full Text] [Related]
18. [CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas].
Avilés A; Huerta J; Guzmán R; Zepeda G; Díaz-Maqueo JC
Rev Invest Clin; 1990; 42(4):271-6. PubMed ID: 1708910
[TBL] [Abstract][Full Text] [Related]
19. [Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Montalbán C; Arechaga S; Calleja JL; Bellas C; Patier JL; Berenguer A; García Villanueva A; Marcos Robles J
Med Clin (Barc); 1990 Mar; 94(12):461-4. PubMed ID: 1694944
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors.
Ibrahim EM; Bunyan RF; al-Mulhim FA; al-Nabhan AA; Ibrahim RE
Acta Haematol; 1996; 96(3):126-34. PubMed ID: 8876608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
